In order to further explore the mechanism of MuRF-1 involved in IMNM, immunostaining was performed in biopsies from IMNM, DM, dysferlinopathy and controls. This evidence concerns the gene TRIM63 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.